Al-Dawaa Medical Services Company (TADAWUL: 4163)

Market Cap	7.96B
Revenue (ttm)	6.00B
Net Income (ttm)	354.84M
Shares Out	85.00M
EPS (ttm)	4.17
PE Ratio	22.42
Forward PE	19.27
Dividend	1.25 (1.34%)
Ex-Dividend Date	Aug 12, 2024

Volume	38,170
Open	92.30
Previous Close	92.10
Day's Range	92.30 - 93.60
52-Week Range	80.90 - 121.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Al-Dawaa Medical Services Company

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products. It is also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marke...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2023, Al-Dawaa Medical Services Company's revenue was 5.74 billion, an increase of 6.87% compared to the previous year's 5.37 billion. Earnings were 329.22 million, an increase of 7.78%.